Herbs and plantsRibwort plantain — a weed by the fence more effective than pharmacy syrup?
- Henryk Różański — Babka lancetowata – Plantago lanceolata L. wg współczesnych badań
- Henryk Różański — Plantago lanceolata Linne – Babka lancetowata w XIX wieku
- Effect of Plantago major on cough severity in acute bronchitis: A double-blind randomized clinical trial. · Caspian J Intern Med 2024
- The therapeutic effects of Plantago major and its main constituents on respiratory diseases: a narrative review. · Naunyn Schmiedebergs Arch Pharmacol 2025
- Efficacy and safety of the syrup "KalobaTUSS®" as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial. · BMC Pediatr 2021
Henryk Różański describes ribwort plantain as a plant that soothes coughs, especially in syrups.
- It is used for colds and inflammation of the throat and bronchi.
- Różański attributes anti-inflammatory and antibacterial effects to it, and says its constituents hinder the spread of rhinovirus infections.
- In the past, infusions and macerations of plantain were used for respiratory diseases, and an infusion was used to gargle and rinse the mouth.
What the authors write
Ribwort plantain soothes coughs, especially in syrups, and is used for colds and inflammation of the throat and bronchi.
The effects described for plantain include antibacterial and anti-inflammatory effects.
Plantain constituents are said to hinder the spread of rhinovirus infections.
In the past, infusions and macerations of plantain were used for respiratory diseases, and an infusion was used to gargle and rinse the mouth during inflammation.
An old account described plantain as useful for phlegm in the lungs.
Research from PubMed · Europe PMC
We selected 3 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 15.
In a study, Plantago major syrup reduced cough severity and several cough symptoms more than a placebo after 10 days.
Aim of the study: Treatment for acute bronchitis is usually supportive care to relieve upper respiratory symptoms. This study aimed to evaluate the effect of Plantago major syrup (PMS) on cough severity in acute bronchitis.
Results: Of the 121 patients diagnosed with acute bronchitis, 80 eligible patients (aged 42.87±11.75 years) were randomly divided into PMS and placebo groups. After 10 days, the BSS score in the PMS group was significantly lower than in the placebo group (P=0.001). Cough frequency (P=0.001), sputum production (P=0.005), and chest wall pain (P=0.008) were significantly lower in the PMS group than in the placebo group. In terms of quality of life, all items, including psychological, physical, and social domains, as well as total scores, changed significantly in the PMS group compared with the placebo group. During monitoring of side effects, no significant adverse effects were reported in either group. The study indicates that PMS has a palliative effect in relieving the symptoms of acute bronchitis and improving quality of life.
“Not stated” does not mean nobody paid — the database does not always record it.
The review describes clinical studies in which the use of Plantago major was associated with reduced coughing and wheezing and improvements in some respiratory measures.
Aim of the study: Herbal medicines have been proposed as adjuvant treatment for respiratory diseases. One such agent is Plantago major (P.
Results: In clinical studies, a significant reduction in cough and wheezing, increases in FEV1 and FVC in patients with asthma, a rapid effect on the signs and symptoms of bronchitis, and antiviral effects were observed. Despite in vitro and animal studies, there are few clinical studies on the respiratory effects of P. major in humans. Therefore, further clinical studies should be designed to identify the respiratory effects of the plant and its derivatives.
“Not stated” does not mean nobody paid — the database does not always record it.
In children, a combination syrup containing Plantago major extract was associated with less severe and shorter-lasting cough than a placebo.
Aim of the study: Acute cough in children often causes discomfort to children and parents, reducing their quality of life. Despite the extensive use of over-the-counter remedies for cough, the efficacy of most of these treatments in children has not been confirmed.
Results: Children were given KalobaTUSS® or a placebo orally for 8 days. Children receiving KalobaTUSS® showed an early and significant reduction in night-time and daytime cough scores measured using a specific scale, and a shorter duration of cough than children treated with the placebo. KalobaTUSS® is well tolerated and has positive effects, reducing cough severity and shortening its duration in children.
“Not stated” does not mean nobody paid — the database does not always record it.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.